Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Phil Humphreys's Biography

Phil Humphreys, Senior Scientific Investigator, GlaxoSmithKline

Phil Humphreys is a Scientific Leader and medicinal chemist in the Epigenetics Discovery Performance Unit in GlaxoSmithKline Stevenage. He studied Biochemistry and Biological Chemistry at the University of Nottingham before organic chemistry PhD. studies under the supervision of Prof. David Hodgson at the University of Oxford. Phil then completed his postdoctoral studies in the laboratory of Prof. Larry Overman at the University of California, Irvine as a Merck Sharp & Dohme Postdoctoral Research Fellow working on the total synthesis of alkaloid natural products. He began his medicinal chemistry career in 2009, joining the immune memory DPU in GSK, Stevenage before transitioning to the Epinova Epigenetics DPU in early 2010 where he has worked since. Phil has led programmes on a variety of targets in the epigenetic space, and has a particular interest in bromodomain chemical probes.

Phil Humphreys Image

The Development Of non-BET Bromodomain Chemical Probes

Tuesday, 7 March 2017 at 15:15

Add to Calendar ▼2017-03-07 15:15:002017-03-07 16:15:00Europe/LondonThe Development Of non-BET Bromodomain Chemical

This talk will describe the development of a bromodomain inhibitor discovery platform at GlaxoSmithKline and its application to the development of a PCAF/GCN5 bromodomain chemical probe.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonEpigenetics in Drug